Lexaria Bioscience Ownership | Who Owns Lexaria Bioscience?

Lexaria Bioscience Ownership Summary

Lexaria Bioscience is owned by 12.55% institutional investors, 7.14% insiders, and 80.31% retail investors. Sabby management is the largest institutional shareholder, holding 6.37% of LEXX shares. Invenomic Institutional is the top mutual fund, with 1.42% of its assets in Lexaria Bioscience shares.

LEXX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexaria Bioscience	12.55%	7.14%	80.31%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Sabby management	1.17M	6.37%	$1.01M
Invenomic capital management lp	501.47K	2.74%	$436.28K
Geode capital management	166.68K	1.00%	$350.11K
Vanguard group	127.43K	0.76%	$267.61K
Toronto dominion bank	133.13K	0.73%	$115.89K
Raymond james financial services advisors	48.80K	0.35%	$135.66K
State street	39.30K	0.24%	$82.53K
Blackrock	27.45K	0.20%	$76.30K
Morgan stanley	22.98K	0.17%	$63.89K
Blackrock funding, inc. /de	27.45K	0.15%	$23.88K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sabby management	1.17M	1.84%	$1.01M
Invenomic capital management lp	501.47K	0.02%	$436.28K
Byrne asset management	13.00K	0.02%	$27.30K
Oakworth capital	5.00K	0.00%	$4.35K
Raymond james financial services advisors	48.80K	0.00%	$135.66K
Toronto dominion bank	133.13K	0.00%	$115.89K
Wealth enhancement advisory services	13.82K	0.00%	$42.16K
Tower research capital llc (trc)	2.08K	0.00%	$4.37K
Advisor group	2.29K	-	$6.51K
Scotia capital	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Sabby management	1.17M	1.84%	1.17M
Blackrock	27.45K	-	25.94K
Vanguard group	127.43K	-	18.41K
Geode capital management	166.68K	-	16.29K
Raymond james financial services advisors	48.80K	0.00%	9.25K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-460.00K
Raymond james financial	-	-	-61.25K
Gentrust	-	-	-60.00K
Invenomic capital management lp	501.47K	0.02%	-48.48K
Welch group	-	-	-24.00K

New Positions

Holder	Shares	% Assets	Change	Value
Sabby management	1.17M	1.84%	1.17M	$1.01M

Sold Out

Holder	Change
Northwestern mutual wealth management	-9.00
Sound income strategies	-22.00
Allworth financial lp	-89.00
Mather group, llc.	-100.00
Ubs group	-116.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	21	-4.55%	2,297,063	85.28%	12	25.05%	8	-20.00%	3	-25.00%
Mar 31, 2025	1	-96.00%	549,947	-61.85%	3	4.20%	1	-92.31%	-	-100.00%
Dec 31, 2024	25	-7.41%	1,426,411	33.73%	8	14.44%	12	9.09%	2	-50.00%
Sep 30, 2024	26	-7.14%	1,061,074	-48.44%	7	3.47%	10	-28.57%	4	33.33%
Jun 30, 2024	28	12.00%	2,057,835	131.53%	14	21.79%	14	-12.50%	3	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invenomic Institutional	276.79K	1.42%	77.77K
Vanguard Institutional Extnd Mkt Idx Tr	126.64K	0.65%	3.29K
Fidelity Extended Market Index	86.92K	0.44%	-227.00
BlackRock Extended Equity Market K	22.61K	0.14%	-10.00
Fidelity Total Market Index	26.29K	0.13%	-
Fidelity Series Total Market Index	22.20K	0.11%	-
Extended Equity Market Fund K	21.93K	0.11%	-438.00
Spartan Extended Market Index Pool E	17.81K	0.10%	755.00
Spartan Extended Market Index Pool F	18.83K	0.10%	-
Northern Trust Extended Eq Market Idx	12.25K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 30, 2025	BUNKA CHRISTOPHER	-	Buy	$10.87K
Jul 29, 2025	BUNKA CHRISTOPHER	-	Buy	$14.38K
Jul 29, 2025	McKechnie William Edward	-	Buy	$4.53K
Jul 29, 2025	DOCHERTY JOHN MARTIN	President & CSO	Buy	$4.99K
Jul 29, 2025	Carle Vanessa	Secretary	Buy	$682.50

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	6	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	1	1
2024 Q2	-	-

LEXX Ownership FAQ

Who Owns Lexaria Bioscience?

Lexaria Bioscience shareholders are primarily institutional investors at 12.55%, followed by 7.14% insiders and 80.31% retail investors. The average institutional ownership in Lexaria Bioscience's industry, Biotech Stocks , is 306.59%, which Lexaria Bioscience falls below.

Who owns the most shares of Lexaria Bioscience?

Lexaria Bioscience’s largest shareholders are Sabby management (1.17M shares, 6.37%), Invenomic capital management lp (501.47K shares, 2.74%), and Geode capital management (166.68K shares, 1.00%). Together, they hold 10.11% of Lexaria Bioscience’s total shares outstanding.

Does Blackrock own Lexaria Bioscience?

Yes, BlackRock owns 0.20% of Lexaria Bioscience, totaling 27.44K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 76.3K$. In the last quarter, BlackRock increased its holdings by 25.94K shares, a 1719.96% change.

Who is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested?

Sabby management is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested, with 1.84% of its assets in 1.17M Lexaria Bioscience shares, valued at 1.01M$.

Who is the top mutual fund holder of Lexaria Bioscience shares?

Invenomic Institutional is the top mutual fund holder of Lexaria Bioscience shares, with 1.42% of its total shares outstanding invested in 276.79K Lexaria Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools